Allogeneic bone marrow transplantation for hypereosinophilic syndrome with advanced myelofibrosis.
A 33-year-old man with an atypical course of hypereosinophilic syndrome including malignant hypercalcemia, osteolytic lesions and evolution into severe myelofibrosis was treated by allogeneic bone marrow transplantation after conditioning with cytoxan and total body irradiation. As the transplant was sex-mismatched, chimerism was studied by means of cytogenetic analysis and Y chromosomal DNA amplification by PCR assay. Long-term complete remission has been assessed by normalization of blood cell counts, magnetic resonance imaging and karyotypic analysis. A relapse was observed 40 months after transplantation. The patient remains alive 44 months post-BMT. This case report is compared with those reported in the literature.
Sadoun
A
A
Département d'Hématologie et Oncologie Médicale, CHU La Milétrie, Poitiers, France.
Lacotte
L
L
Delwail
V
V
Randriamalala
E
E
Patri
S
S
Babin
P
P
Brizard
A
A
Guilhot
F
F
D000328:Adult; D016026:Bone Marrow Transplantation; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D055728:Primary Myelofibrosis / Q000628:therapy*; D014184:Transplantation, Homologous